首页> Journal of acquired immune deficiency syndromes (1999)> Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.

Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.

导出 OA

翻译打印收藏纠错

第一作者： Ahmed M,Bayoumi

第一单位： *Center for Research on Inner City Health, The Keenan Research Center in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; †Department of Medicine, University of Toronto, Toronto, Ontario, Canada; ‡Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada; §Division of General Internal Medicine, St. Michael's Hospital, Toronto, Ontario, Canada; ‖VA Palo Alto Health Care System, VA Cooperative Studies Program Coordinating Center, VA HSR&D Health Economics Resource Center, Menlo Park, CA; ¶Center for Health Economics, University of York, York, United Kingdom; #Center for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada **CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada; ††School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; ‡‡VA Palo Alto Health Care System, Palo Alto, CA; §§Department of Medicine, Stanford University, Stanford, CA; ‖‖Duke Clinical Research Institute, Duke University, Durham, NC; ¶¶James J. Peters VA Medical Center, Bronx, NY; ##Department of Medicine, Mt. Sinai School of Medicine, New York, NY; ***VA Cooperative Studies Program Coordinating Center, West Haven, CT; †††MRC Clinical Trials Unit, London, United Kingdom; ‡‡‡Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; §§§The University of Ottawa at The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and ‖‖‖Center for Primary Care and Outcomes Research and Center for Health Policy, Stanford University, Stanford, CA.

作者： Ahmed M,Bayoumi ^[1] ; Paul G,Barnett ; Vilija R,Joyce ; Susan C,Griffin ; Huiying,Sun ; Nick J,Bansback ; Mark,Holodniy ; Gillian,Sanders ; Sheldon T,Brown ; Tassos C,Kyriakides ; Brian,Angus ; D William,Cameron ; Aslam H,Anis ; Mark,Sculpher ; Douglas K,Owens

作者单位： *Center for Research on Inner City Health, The Keenan Research Center in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; †Department of Medicine, University of Toronto, Toronto, Ontario, Canada; ‡Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada; §Division of General Internal Medicine, St. Michael's Hospital, Toronto, Ontario, Canada; ‖VA Palo Alto Health Care System, VA Cooperative Studies Program Coordinating Center, VA HSR&D Health Economics Resource Center, Menlo Park, CA; ¶Center for Health Economics, University of York, York, United Kingdom; #Center for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada **CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada; ††School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; ‡‡VA Palo Alto Health Care System, Palo Alto, CA; §§Department of Medicine, Stanford University, Stanford, CA; ‖‖Duke Clinical Research Institute, Duke University, Durham, NC; ¶¶James J. Peters VA Medical Center, Bronx, NY; ##Department of Medicine, Mt. Sinai School of Medicine, New York, NY; ***VA Cooperative Studies Program Coordinating Center, West Haven, CT; †††MRC Clinical Trials Unit, London, United Kingdom; ‡‡‡Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; §§§The University of Ottawa at The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and ‖‖‖Center for Primary Care and Outcomes Research and Center for Health Policy, Stanford University, Stanford, CA. ^[1]